Generic Name(s): Ado-Trastuzumab Emtansine
Kadcyla is the trade name for ado-trastuzumab emtansine. In some cases, health care professionals may use the trade name Kadcyla when referring to the generic drug name ado-trastuzumab emtansine.
Drug type: Kadcyla is an Anti-HER2 monoclonal antibody combined with a microtubular inhibitor. (For more detail, see "How this drug works" section below).
What this drug is used for:
Kadcyla is used as a single agent to treat HER2-positive, metastatic breast cancer who previously received trastuzumab and a taxane, separately or in combination. Patients should have either:
Note: If a drug has been approved for one use, physicians may elect to use this same drug for other problems if they believe it may be helpful
How this drug is given:
The amount of Kadcyla that you will receive depends on many factors, including your weight, your general health or other health problems, and the type of cancer or condition being treated. Your doctor will determine your dose and schedule.
Kadcyla Side effects:
Important things to remember about the side effects of Kadcyla:
The following side effects are common (occurring in greater than 30%) for patients taking Kadcyla :